Codexis

CDXS

Codexis, Inc. is a leading protein engineering company that applies its CodeEvolver platform technology to create high-performing enzymes for improving the cost and quality of pharmaceuticals and food ingredients, to enable sequencing of minute quantities of DNA for medical diagnostics, and to create novel biotherapeutics.

Codexis has been a target of short sellers for a while. The current short interest of 3.51% is roughly at the average of the last 12 months (4.91%).